| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/03/2009 | US7485419 Biosensors based on directed assembly of particles |
| 02/03/2009 | US7485417 Primers for use as amplification and diagnostic tools in genetic engineering |
| 02/03/2009 | US7485415 Sequence analysis of the tetravalent rotavirus vaccine |
| 02/03/2009 | US7485414 Identifying antagonist and/or agonist of neovascularization for treatment and prevention of cancer, reproductive, skin, visual and wound healing disorders |
| 02/03/2009 | US7485321 Synthetic polypeptide ligand having a 12-mer L-peptide for targeting pharmaceutical agents to intestinal epithelial tissue; when integrated as an N-terminal PIII fusion peptide of an M13 phage it can bind the phage to Caco-2 cell, IEC-6 cell, rat, mouse, pig or dog homogenate membrane fractions |
| 02/03/2009 | US7485313 Administering an isolated and purified recombinant Chlamydia trachomatis pgp3 protein having its native amino acid conformation to elicit an immune response to a recombinant Chlamydia trachomatis pgp3 protein |
| 02/03/2009 | US7485307 Protein consisting of specific amino acid sequences or a homolog of the protein; catalyzes the formation of cystathionine and does not bind heme |
| 02/03/2009 | US7485306 Lutzomyia longipalpis polypeptides and methods of use |
| 02/03/2009 | US7485301 Complexing, therapy, prophylaxis, medical diagnosis; antibodies, antigen binding to chemokine |
| 02/03/2009 | US7485291 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 02/03/2009 | CA2519824C Barley lipoxygenase-1 gene, selection method for barley, materials for malt alcoholic beverages and method for production of malt alcoholic beverages |
| 02/03/2009 | CA2509100C Plants having modified growth characteristics and a method for making the same |
| 02/03/2009 | CA2440504C Magnetic pigment |
| 02/03/2009 | CA2423916C Compounds with a branched linker |
| 02/03/2009 | CA2291883C Trigger factor expression plasmids |
| 02/03/2009 | CA2287914C Raffinose synthase gene, method for producing raffinose, and transgenic plant |
| 02/03/2009 | CA2286165C A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 02/03/2009 | CA2261994C Frozen food product containing heat stable antifreeze protein |
| 02/03/2009 | CA2240609C A method for generating hypermutable organisms |
| 02/03/2009 | CA2229075C Methods of using nucleotide integrase for cleaving dna and attaching nucleic acids |
| 02/03/2009 | CA2206102C Comparative fluorescence hybridization to nucleic acid arrays |
| 02/03/2009 | CA2177600C Regulatory nucleic acid sequences and uses thereof |
| 02/03/2009 | CA2169315C Primers and probes for the detection of hiv |
| 02/03/2009 | CA2152066C Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 02/03/2009 | CA1341590C Human immune interferon |
| 01/29/2009 | WO2009015290A1 Systems and methods for isolating nucleic acids |
| 01/29/2009 | WO2009015268A2 Engineered glycosyltransferases with expanded substrate specificity |
| 01/29/2009 | WO2009015165A1 Solubility tags for the expression and purification of bioactive peptides |
| 01/29/2009 | WO2009015159A1 Method for recovering sperm nucleic acid from a forensic sample |
| 01/29/2009 | WO2009015143A1 Biodegradable cationic polymer gene transfer compositions and methods of use |
| 01/29/2009 | WO2009015096A2 Glutamate receptor associated genes and proteins for enhancing nitrogen utilization efficiency in crop plants |
| 01/29/2009 | WO2009015079A1 Modification of plant disease resistance |
| 01/29/2009 | WO2009015036A1 Parthenote-derived stem cells and methods of making and using them |
| 01/29/2009 | WO2009015011A1 Natriuretic polypeptides |
| 01/29/2009 | WO2009014919A2 H2n3 influenza a viruses and methods of use |
| 01/29/2009 | WO2009014766A2 Non-invasive recovery of rna and analysis of gene expression in skin |
| 01/29/2009 | WO2009014726A1 Methods for enhancing bacterial cell display of proteins and peptides |
| 01/29/2009 | WO2009014665A2 Transgenic plants with enhanced agronomic traits |
| 01/29/2009 | WO2009014462A1 Methods and polynucleotides for improving plants |
| 01/29/2009 | WO2009014445A2 Baculoviral vectors comprising repeated coding sequences with differential codon biases |
| 01/29/2009 | WO2009014437A1 Production of itaconic acid |
| 01/29/2009 | WO2009014430A1 Novel polygalacturonases and their uses |
| 01/29/2009 | WO2009014415A1 A method, kit and apparatus for extracting biological materials |
| 01/29/2009 | WO2009014410A1 Method for producing cloned bovine embyros |
| 01/29/2009 | WO2009014328A1 A plant recombinant human ctla4ig and a method for producing the same |
| 01/29/2009 | WO2009014269A1 Method of identifying the species of plant belonging to the genus uncaria |
| 01/29/2009 | WO2009014216A1 Antibody having inhibitory activity on infection with hepatitis c virus (hcv), and use thereof |
| 01/29/2009 | WO2009014207A1 Test method on feline vaccinated with feline immunodeficiency virus vaccine, and antigen for use in the test |
| 01/29/2009 | WO2009014160A1 Novel tumor marker for pancreatic cancer |
| 01/29/2009 | WO2009014140A1 Fatty acid composition having novel fatty acid contents |
| 01/29/2009 | WO2009014117A1 Method for production of l-lysine |
| 01/29/2009 | WO2009014036A1 Method for obtaining information on biological rhythm by using hair |
| 01/29/2009 | WO2009013745A1 Photocatalytic hydrogen production and polypeptides capable of same |
| 01/29/2009 | WO2009013622A2 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 01/29/2009 | WO2009013621A2 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis |
| 01/29/2009 | WO2009013611A2 Modified esterase and its applications |
| 01/29/2009 | WO2009013569A1 Pharmaceutical composition and pharmaceutical kit for the treatment of hepatocellular carcinoma |
| 01/29/2009 | WO2009013559A1 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 01/29/2009 | WO2009013468A2 Late blight resistance genes and methods |
| 01/29/2009 | WO2009013461A1 Growth hormone fusion proteins |
| 01/29/2009 | WO2009013448A2 Herpesviruses having altered target cell specificity |
| 01/29/2009 | WO2009013382A1 Method for genetically modifying woody plants by using cells with meristematic capacity |
| 01/29/2009 | WO2009013379A1 Attenuated live strain of salmonella enterica serovar choleraesuis as a vaccine and vaccinal vehicle for swine livestock |
| 01/29/2009 | WO2009013324A1 Vector particles for targeting cd34+ cells |
| 01/29/2009 | WO2009013290A1 Cns gene delivery using peripheral administration of aav vectors |
| 01/29/2009 | WO2009013263A2 Plants having increased yield-related traits and a method for making the same |
| 01/29/2009 | WO2009013225A2 Plants having enhanced yield-related traits and a method for making the same |
| 01/29/2009 | WO2009013160A2 Butanol production in a eukaryotic cell |
| 01/29/2009 | WO2009013159A2 Acetyl-coa producing enzymes in yeast |
| 01/29/2009 | WO2009013158A1 Butanol production in a eukaryotic cell |
| 01/29/2009 | WO2009013157A1 Butanol production in a eukaryotic cell |
| 01/29/2009 | WO2009012786A2 Nanoparticle-mediated treatment for inflammatory diseases |
| 01/29/2009 | WO2009012600A1 Fusion proteins |
| 01/29/2009 | WO2009012588A1 Immunogenic polypeptides and monoclonal antibodies |
| 01/29/2009 | WO2008146272A3 Compositions and methods for treating cxcr6/cxcl16 associated diseases |
| 01/29/2009 | WO2008145708A3 Aromatic alcohols for the treatment of a biological sample |
| 01/29/2009 | WO2008145140A3 Transgenic animals producing monovalent human antibodies and antibodies obtainable from these animals |
| 01/29/2009 | WO2008131155A3 Corn plants and seed enhanced for asparagine and protein |
| 01/29/2009 | WO2008127680A3 Diagnosis and treatment of diseases caused by misfolded proteins |
| 01/29/2009 | WO2008122598A3 Respiratory syncytial virus (rsv) viral load detection assay |
| 01/29/2009 | WO2008122441A3 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
| 01/29/2009 | WO2008115296A3 Modified phage for displaying post-translationally modified proteins and uses thereof |
| 01/29/2009 | WO2008112645A3 Methods for plant transformation using spectinomycin selection |
| 01/29/2009 | WO2008109490A3 Nucleic acid compounds for inhibiting chek1 gene expression and uses thereof |
| 01/29/2009 | WO2008109378A3 Nucleic acid compounds for inhibiting pdgfr gene expression and uses thereof |
| 01/29/2009 | WO2008109370A4 Nucleic acid compounds for inhibiting srd5a1 gene expression and uses thereof |
| 01/29/2009 | WO2008109369A4 Nucleic acid compounds for inhibiting tnf gene expression and uses thereof |
| 01/29/2009 | WO2008109368A4 Nucleic acid compounds for inhibiting vegfr gene expression and uses thereof |
| 01/29/2009 | WO2008109366A4 Nucleic acid compounds for inhibiting ccnd1 gene expression and uses thereof |
| 01/29/2009 | WO2008091375A3 Attenuated salmonella as a delivery system for sirna-based tumor therapy |
| 01/29/2009 | WO2008022152A3 Optimized antibodies that target cd19 |
| 01/29/2009 | WO2008010101A9 Antagonist antibody against epha2 for the treatment of cancer |
| 01/29/2009 | WO2007148926A9 Tfla gene which can degrade toxoflavin and its chemical derivatives and transgenic organisms expressing tfla gene |
| 01/29/2009 | WO2007140339A3 Production of isoprenoids |
| 01/29/2009 | WO2007094667A9 Methods and means for metabolic engineering and improved product formation by micro-organisms |
| 01/29/2009 | WO2007089780A3 Bmx/etk tyrosine kinase gene therapy materials and methods |
| 01/29/2009 | WO2007087451A3 Compositions and methods for enhancing discriminatory rna interference |
| 01/29/2009 | WO2006138005A3 Genes and uses for plant improvement |
| 01/29/2009 | WO2005098010A9 Novel method of generating non-human transgenic animals, and transgenic animals thus obtained |
| 01/29/2009 | US20090031458 Thaumatin From Transgenic Barley |